Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis

Completed · Phase 2

Conditions studied: Renal Osteodystrophy, End Stage Renal Disease

In brief

OBJECTIVES: I. Evaluate the separate and combined skeletal effects of recombinant human growth hormone (GH) and calcitriol in patients with adynamic renal osteodystrophy. II. Assess whether calcium-regulated changes in parathyroid hormone secretion predict changes in bone formation. III. Characterize the response to GH in cancellous bone and in growth plate cartilage in patients with secondary hyperparathyroidism during calcitriol therapy.

Key facts

Study ID

NCT00004340

Run by

National Center for Research Resources (NCRR)

People needed

109

Starts

1995-06-01

Last updated by the study team

2005-06-24

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of California Los Angeles School of Medicine — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.